ERBB2 Exon 20 Mutation-Guided Trastuzumab Deruxtecan Therapy in Metastatic Lung Adenocarcinoma with Low HER2 Expression: A Case Report

Zhao-Feng Gao, Xu Wen, Jia-Qi Yu, Jun Zhang, Qian-Yu Chen, Xin-Wei Zhou, Xue-Song He, Peng-Li Wang

Open source

DOI: 10.2147/ott.s653854
Published: 2026-11
Container: OncoTargets and Therapy
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/ott.s653854,
  title = {ERBB2 Exon 20 Mutation-Guided Trastuzumab Deruxtecan Therapy in Metastatic Lung Adenocarcinoma with Low HER2 Expression: A Case Report},
  author = {Zhao-Feng Gao and Xu Wen and Jia-Qi Yu and Jun Zhang and Qian-Yu Chen and Xin-Wei Zhou and Xue-Song He and Peng-Li Wang},
  year = {2026},
  journal = {OncoTargets and Therapy},
  doi = {10.2147/ott.s653854},
  url = {https://doi.org/10.2147/ott.s653854}
}

RIS

TY  - JOUR
TI  - ERBB2 Exon 20 Mutation-Guided Trastuzumab Deruxtecan Therapy in Metastatic Lung Adenocarcinoma with Low HER2 Expression: A Case Report
AU  - Zhao-Feng Gao
AU  - Xu Wen
AU  - Jia-Qi Yu
AU  - Jun Zhang
AU  - Qian-Yu Chen
AU  - Xin-Wei Zhou
AU  - Xue-Song He
AU  - Peng-Li Wang
PY  - 2026
JO  - OncoTargets and Therapy
DO  - 10.2147/ott.s653854
UR  - https://doi.org/10.2147/ott.s653854
ER  -

APA

Gao, Z., Wen, X., Yu, J., Zhang, J., Chen, Q., Zhou, X., He, X., & Wang, P. (2026). ERBB2 Exon 20 Mutation-Guided Trastuzumab Deruxtecan Therapy in Metastatic Lung Adenocarcinoma with Low HER2 Expression: A Case Report. OncoTargets and Therapy. https://doi.org/10.2147/ott.s653854

Source records

crossref · retrieved 2026-11-10T02:31:24.857Z